HCS Pharma is a biotechnology start-up that offers services in pre-clinical in vitro research. Expertise: the development of new in vitro tests in pharmacology and their use in medium / high throughput screening in cell imaging: "High Content Analysis" (HCA) / "High Content Screening" (HCS). Its areas of expertise: neurodegenerative diseases (Parkinson, Alzheimer, ...), oncology, toxicology (hepatotoxicology ...).
Nathalie Maubon, the CEO ad CSO, has 15 years of experience in the development of cellular models and process automation including 10 years in the pharmaceutical industry. Julian Bursztyka, the COO, has 10 years of experience in research including 5 years in services for pharmaceutical industry clients.
